CoChat

Inhibitory Effect of Morin Against Candida albicans Pathogenicity and Virulence Factor Production: An in vitro and in vivo Approaches

Open access
Abirami, Gurusamy, Alexpandi, Rajaiah, Durgadevi, Ravindran, Kannappan, Arunachalam, Veera Ravi, Arumugam · 2020 · Frontiers in Microbiology
Cited by 67

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Candida albicans is considered as an exclusive etiologic agent of candidiasis, a very common fungal infection in human. The expression of virulence factors is highly contributing to the pathogenicity of C. albicans. These factors include biofilm formation, yeast to hyphal transition, adhesins, aspartyl proteases, and phospholipases secretion. Moreover, resistance development is the critical issue for the therapeutic failure of antifungal agents against systemic candidiasis. To circumvent the resistance development, the present study investigated the virulence targeted therapeutic activity of the phyto-bioactive compound morin against C. albicans. Morin, a natural compound commonly found in medicinal plants and widely used in the pharmaceutical and cosmetic products/industries. The present study explicated the significant inhibitory potential of morin against the biofilm formation and other virulence factors production such as yeast-hyphal formation, phospholipase and exopolymeric substances in C. albicans. Further, qPCR analysis confirmed the downregulation of biofilm and virlence-related genes in C. albicans upon morin treatment, which is in correspondence with the in vitro bioassays. Further, the docking analysis revealed that morin shows strong affinity with Hwp-1 protein, which regulates the expression of biofilm as well as hyphal formation in C. albicans and, thereby, abolishes fungal pathogenicity. Moreover, the anti-infective potential of morin against C. albicans associated systemic candidiasis is confirmed through in vivo approach using biomedical model organism zebrafish (Danio rerio). The outcomes of in vivo study demonstrate that the morin treatment effectively rescues animals from C. albicans infections and extends their survival rate by inhibiting the internal colonization of C. albicans. Histopathology analysis revealed an extensive candidiasis-related pathognomonic changes in gills, intestine, and kidney of C. albicans infected animal, while no extensive abnormalities were observed in morin treated animals. The results evidenced that morin has the ability to protect the pathognomonic effect and histopathological lesions caused by C. albicans infection in zebrafish. Thus the present study suggests that the utilization of morin could act as a potent therapeutic medication for C. albicans instigated candidiasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2020.561298

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 67

Metadata

Authors
Abirami, G., Alexpandi, R., Durgadevi, R., Kannappan, A., & Veera Ravi, A.
Venue
Frontiers in Microbiology
Published
2020-10-23
Volume
11
Pages
561298-561298
ISSN
1664-302X (ISSN-L)
OpenAlex
W3093656238
Cited by
67
References
8
FWCI
1.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.